Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

Published 2012 | Version v1.0.0
Journal Article Open

Thrombotic and bleeding complications associated with chemotherapy


It is well recognized that cancer patients have an increased risk of thrombosis and bleeding. Contributory factors to thrombotic complications include prothrombotic risks carried by many chemotherapeutic agents, type of cancer, stage of cancer, age, and comorbidities. Surgical procedures and the presence of an indwelling vascular device, often used as a mode of delivery for chemotherapy, further increase the risk. Correlative studies have demonstrated upregulation of coagulation in response to chemotherapeutics, and clinical studies have shown that various cancer treatments are independent risk factors for thrombotic complications. It has also been shown that patients who develop thrombosis during treatment have a worse overall prognosis. Mechanisms for chemotherapy and cancer-associated thrombosis are not well understood. Better insight into the mechanism for thrombosis may help better identify those cancer patients at highest risk, who may then benefit from up-front anticoagulant prophylaxis.


original_citation: McMahon, B. J., & Kwaan, H. C. (2012). Thrombotic and bleeding complications associated with chemotherapy. Semin Thromb Hemost, 38(8), 808-817. doi:10.1055/s-0032-1328885


Files (815.7 kB)
Name Size Download all
815.7 kB Preview Download

Additional details

March 30, 2023
March 30, 2023